Financials

Discussions Technicals Seasonals

6617 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to GONGWIN BIOPHARM HOLDINGS CO LTD operating, investing, and financing activities

6617 free cash flow for Q3 24 is -26.09 M TWD. For 2023, 6617 free cash flow was -111.7 M TWD and operating cash flow was -110.8 M TWD.

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—